Gilead Sciences Statistics Share Statistics Gilead Sciences has 1.24B
shares outstanding. The number of shares has increased by -0.09%
in one year.
Shares Outstanding 1.24B Shares Change (YoY) -0.09% Shares Change (QoQ) -0.11% Owned by Institutions (%) 82.36% Shares Floating 1.24B Failed to Deliver (FTD) Shares 705 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 22.54M, so 1.81% of the outstanding
shares have been sold short.
Short Interest 22.54M Short % of Shares Out 1.81% Short % of Float 1.81% Short Ratio (days to cover) 3.91
Valuation Ratios The PE ratio is 239.97 and the forward
PE ratio is 13.93.
Gilead Sciences's PEG ratio is
-2.62.
PE Ratio 239.97 Forward PE 13.93 PS Ratio 4.01 Forward PS 5 PB Ratio 5.96 P/FCF Ratio 11.18 PEG Ratio -2.62
Financial Ratio History Enterprise Valuation Gilead Sciences has an Enterprise Value (EV) of 131.91B.
EV / Sales 4.59 EV / EBITDA 29.75 EV / EBIT 12.18 EV / FCF 12.8
Financial Position The company has a current ratio of 1.6,
with a Debt / Equity ratio of 1.38.
Current Ratio 1.6 Quick Ratio 1.45 Debt / Equity 1.38 Debt / EBITDA 6.02 Debt / FCF 2.59 Interest Coverage 1.7
Financial Efficiency Return on Equity is 2.48% and Return on Invested Capital is 2.36%.
Return on Equity 2.48% Return on Assets 0.81% Return on Invested Capital 2.36% Revenue Per Employee $1.63M Profits Per Employee $27.27K Employee Count 17,600 Asset Turnover 0.49 Inventory Turnover 3.66
Taxes Income Tax 211M Effective Tax Rate 30.58%
Stock Price Statistics The stock price has increased by 65.19% in the
last 52 weeks. The beta is 0.35, so Gilead Sciences's
price volatility has been higher than the market average.
Beta 0.35 52-Week Price Change 65.19% 50-Day Moving Average 110.97 200-Day Moving Average 102.48 Relative Strength Index (RSI) 63.42 Average Volume (20 Days) 7,602,116
Income Statement In the last 12 months, Gilead Sciences had revenue of 28.75B
and earned 480M
in profits. Earnings per share was 0.38.
Revenue 28.75B Gross Profit 22.5B Operating Income 1.66B Net Income 480M EBITDA 4.43B EBIT 1.67B Earnings Per Share (EPS) 0.38
Full Income Statement Balance Sheet The company has 9.99B in cash and 26.71B in
debt, giving a net cash position of -16.72B.
Cash & Cash Equivalents 9.99B Total Debt 26.71B Net Cash -16.72B Retained Earnings 11.5B Total Assets 56.43B Working Capital 4.56B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 10.83B
and capital expenditures -523M, giving a free cash flow of 10.3B.
Operating Cash Flow 10.83B Capital Expenditures -523M Free Cash Flow 10.3B FCF Per Share 8.26
Full Cash Flow Statement Margins Gross margin is 78.26%, with operating and profit margins of 5.78% and 1.67%.
Gross Margin 78.26% Operating Margin 5.78% Pretax Margin 2.4% Profit Margin 1.67% EBITDA Margin 15.42% EBIT Margin 5.78% FCF Margin 35.84%
Dividends & Yields GILD pays an annual dividend of $3.89,
which amounts to a dividend yield of 2.84%.
Dividend Per Share $3.89 Dividend Yield 2.84% Dividend Growth (YoY) 2.6% Payout Ratio 50.26% Earnings Yield 0.42% FCF Yield 8.95%
Dividend Details Analyst Forecast The average price target for GILD is $120,
which is -0.5% lower than the current price. The consensus rating is "Buy".
Price Target $120 Price Target Difference -0.5% Analyst Consensus Buy Analyst Count 22
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $9.5 Lynch Upside -92.12% Graham Number 11.59 Graham Upside -90.39%
Stock Splits The last stock split was on Jan 28, 2013. It was a
forward
split with a ratio of 2:1.
Last Split Date Jan 28, 2013 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 3.54 Piotroski F-Score 8
